McDonald Ian 13D and 13G filings for Bright Minds Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-05 3:25 pm Unchanged |
2024-10-30 | 13D | Bright Minds Biosciences Inc. DRUG |
McDonald Ian | 1,364,900 23.700% |
0 (Unchanged) |
Filing |
| 2024-11-05 3:21 pm Sale |
2024-10-16 | 13D | Bright Minds Biosciences Inc. DRUG |
McDonald Ian | 1,364,900 24.400% |
-201,610 (-12.87%) |
Filing |
| 2024-02-26 8:18 pm Purchase |
2023-12-22 | 13D | Bright Minds Biosciences Inc. DRUG |
McDonald Ian | 1,566,510 30.560% |
1,353,530 (+635.52%) |
Filing |
| 2024-02-26 8:10 pm Purchase |
2022-12-01 | 13D | Bright Minds Biosciences Inc. DRUG |
McDonald Ian | 212,980 8.880% |
33,900 (+18.93%) |
Filing |
| 2024-01-18 12:57 pm Purchase |
2021-08-16 | 13D | Bright Minds Biosciences Inc. DRUG |
McDonald Ian | 179,080 7.570% |
179,080 (New Position) |
Filing |